Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Hawkeye Politics Today.
Press releases published on July 17, 2025
Levi & Korsinsky Reminds DoubleVerify Holdings, Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of July 21, 2025 – DV
GlobeNewswire
·
July 17, 2025
NEW YORK, July 17, 2025 (GLOBE NEWSWIRE) -- Levi …
Shareholders of PepGen Inc. Should Contact Levi & Korsinsky Before August 8, 2025 to Discuss Your Rights – PEPG
GlobeNewswire
·
July 17, 2025
NEW YORK, July 17, 2025 (GLOBE NEWSWIRE) -- Levi …
RBGLY LAWSUIT ALERT: Levi & Korsinsky Notifies Reckitt Benckiser Group plc Investors of a Class Action Lawsuit and Upcoming Deadline
GlobeNewswire
·
July 17, 2025
NEW YORK, July 17, 2025 (GLOBE NEWSWIRE) -- Levi …
Levi & Korsinsky Reminds Fortrea Holdings Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of August 1, 2025 – FTRE
GlobeNewswire
·
July 17, 2025
NEW YORK, July 17, 2025 (GLOBE NEWSWIRE) -- Levi …
Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of July 22, 2025 in Red Cat Holdings, Inc. Lawsuit – RCAT
GlobeNewswire
·
July 17, 2025
NEW YORK, July 17, 2025 (GLOBE NEWSWIRE) -- Levi …
Lost Money on Petco Health and Wellness Company, Inc. (WOOF)? Join Class Action Suit Seeking Recovery – Contact Levi & Korsinsky
GlobeNewswire
·
July 17, 2025
NEW YORK, July 17, 2025 (GLOBE NEWSWIRE) -- Levi …
Sarepta Therapeutics, Inc. Sued for Securities Law Violations – Investors Should Contact Levi & Korsinsky Before August 25, 2025 to Discuss Your Rights – SRPT
GlobeNewswire
·
July 17, 2025
NEW YORK, July 17, 2025 (GLOBE NEWSWIRE) -- Levi …
HIMS INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Hims & Hers Health, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
GlobeNewswire
·
July 17, 2025
NEW YORK, July 17, 2025 (GLOBE NEWSWIRE) -- Attorney Advertising--Bronstein, Gewirtz …
RDDT INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Reddit, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
GlobeNewswire
·
July 17, 2025
NEW YORK, July 17, 2025 (GLOBE NEWSWIRE) -- Attorney Advertising -- Bronstein, Gewirtz …
OGN INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Organon & Co. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
GlobeNewswire
·
July 17, 2025
NEW YORK, July 17, 2025 (GLOBE NEWSWIRE) -- Attorney Advertising--Bronstein, Gewirtz …
RCKT INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Rocket Pharmaceuticals, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
GlobeNewswire
·
July 17, 2025
NEW YORK, July 17, 2025 (GLOBE NEWSWIRE) -- Attorney Advertising -- Bronstein, Gewirtz …
DBI Investor News: If You Have Suffered Losses in Designer Brands Inc. (NYSE: DBI), You Are Encouraged to Contact The Rosen Law Firm About Your Rights
GlobeNewswire
·
July 17, 2025
NEW YORK, July 17, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of Designer Brands Inc. (NYSE: DBI) resulting from allegations that …
DV DEADLINE: ROSEN, A LEADING LAW FIRM, Encourages DoubleVerify Holdings, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action – DV
GlobeNewswire
·
July 17, 2025
NEW YORK, July 17, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of DoubleVerify Holdings, Inc. (NYSE: DV) between November 10, 2023 and February 27, 2025, both dates inclusive (the “ …
ROSEN, TOP RANKED INVESTOR COUNSEL, Encourages Sarepta Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – SRPT
GlobeNewswire
·
July 17, 2025
NEW YORK, July 17, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Sarepta Therapeutics, Inc. (NASDAQ: SRPT) between June 22, 2023 and June 24, 2025, both dates inclusive (the “Class …
ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Reddit, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – RDDT
GlobeNewswire
·
July 17, 2025
NEW YORK, July 17, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Reddit, Inc. (NYSE: RDDT) between October 29, 2024 and May 20, 2025, both dates inclusive (the “Class Period”), of the …
CLF Investor News: If You Have Suffered Losses in Cleveland-Cliffs Inc. (NYSE: CLF), You Are Encouraged to Contact The Rosen Law Firm About Your Rights
GlobeNewswire
·
July 17, 2025
NEW YORK, July 17, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Cleveland-Cliffs Inc. (NYSE: CLF) resulting from allegations that Cliffs …
ROSEN, A RANKED AND LEADING LAW FIRM, Encourages Biohaven Ltd. Investors to Secure Counsel Before Important Deadline in Securities Class Action – BHVN
GlobeNewswire
·
July 17, 2025
NEW YORK, July 17, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of securities of Biohaven Ltd. (NYSE: BHVN) between March 24, 2023 and May 14, 2025, …
Hims & Hers Health, Inc. (HIMS) Alleged “Deceptive” Marketing of Wegovy® Triggers Securities Class Actions – HIMS Investors with Losses Encouraged to Contact Hagens Berman
GlobeNewswire
·
July 17, 2025
SAN FRANCISCO, July 17, 2025 (GLOBE NEWSWIRE) -- On June 25, 2025, securities class action lawsuits were filed against Hims …
FDA Clinical Hold on RP-A501 Trial Triggers Rocket Pharmaceuticals (RCKT) Stock Plunge and Class Action– Hagens Berman
GlobeNewswire
·
July 17, 2025
SAN FRANCISCO, July 17, 2025 (GLOBE NEWSWIRE) -- When, on May 27, 2025, Rocket Pharmaceuticals (NASDAQ: RCKT) revealed that the FDA put a clinical hold on its Phase 2 pivotal trial for RP-A501, an experimental therapy intended to treat patients with a rare …
Centene Corporation (CNC) Faces Shareholder Ire Amidst Plummeting Stock and Lawsuit Over “Inflated Guidance” – Hagens Berman
GlobeNewswire
·
July 17, 2025
SAN FRANCISCO, July 17, 2025 (GLOBE NEWSWIRE) -- Healthcare giant Centene Corporation (NYSE: CNC), a prominent provider of government-sponsored and commercial healthcare services, finds itself embroiled in a class action lawsuit following a dramatic plunge …